Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
mike, notice that this PR came out on Monday and it took two days for anyone to post it here. Even the FUDsters know this lawsuit is futile.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36766392/slow-market-penetration-for-biogens-another-alzheimers-drug-ubs-highlights-risks-fo
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
Bourbon, in prior discussions with "self-proclaimed" lawyers chiming in, the NDA filing is not considered a material event.
That said, I agree with you that a well-worded PR giving the world as a detailed status report would be greater. Possibly, I guess, it might happen with the Q1 PR and cc in the next 10-14 days. 🤞
Dr. M must be realizing that the competition is failing for one reason or another and criticism is being heaped onto others as negative articles seem to appear daily. I think it is time to release some of the goodies from Santa's bag (but no shiny bikes) that will get people excited while the others are being viewed more negatively than before.
Peace, Bourbon,
powerwalker
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
So, bas, how many of the FUDsters have posted today? I have too many on "ignore" to calculate the count.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
So, Bourbon, how do you know that the NDA has not been filed? It is not required to be PR'ed. Also, filings in Australia may have occurred, too ... or UK ... or EMA. We might here about it if an adcomm review were scheduled.
No one knows "jack"💩 as to what Anavex has done with government agency filings, so far! Until it is PR'ed, we sit 🪑 and wait.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
I let bas and george answer you.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
GREAT FIND, hnbadger!!!
There certainly has been a number of published articles questioning the mabs' efficacy and, respectively, the fda's approval decisions, since the first of the year. It seems that academia and some NFP's are challenging those choices by fda.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
Regardless that info was published last month, it might be that Dr. M wanted folks to know that 3-71 is strong and better than the $14B Karuna's main drug.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
mrp, my comment on transparency has nothing to do with TGD. I stated that the only time a company has to be transparent is if it does or does not receive approval for its drug from one of the agencies. All other statements may seem transparent but, in reality, are very obfuscating ... only the issuers know which is which.
A "Sting" succeeds when the mark(s) believes the web, i.e., lie, being woven is not for them.
I understand. It is a cheap shot at TGD, directly or unintended (not!).
She might be stringing investors along with her supposed "transparency," much like SAVA's and NWBO's leaders continue to do.
Transparency, for a biotech firm, only happens when this 👍️ or this 👎️ is received from a governmental approval agencies.
Of What?
Lawyer talk for your "Prudent" comment.
Red, Fidelity is still under those rate. It is 1.375% for Anavex.
nidan, many here are sorry for the lost of your brother for you and your families ... also, for your loss, bullet, too.
I heard about Alzheimer's in the mid-80's when my aunt was diagnosed with it. My uncle couldn't handle it and died within a year while Aunt Liz lasted until 1988. That is why I've been keen on a solution ever since then and thanks to Patrick Cox, I invested in Anavex in 2008-9. Dr. Missling was the correct move in 2013 (too bad it wasn't made earlier) ...
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
P.S. Great posts by a number of people today, especially you and mrp. Thanks to all.
FYI - While I like the $6.50 range, ANVS is up >$1, to $12.80, but no news given.
What was the change for State Street, Talon?
TIA
I almost choked on my TnT. Very funny 😆
bas and froll, how would you summarize the discussion: was the IR person honest, embellishing, hesitant, confused, engaged, indifferent, too casual, respectful, uninterested in your question et al? Did either of you ask about the status of other drugs as to what Anavex might perceive about its competitors, other that the brain-shrinking mabs?
TIA - I appreciate the thoughts of each of you.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
Only a few weeks away.
Housekeeping items ... and some humor though true:
go avxl - Please change your moniker to "anti-avxl" as nothing you post, comment on or express an emoji is ever a "go avxl" opinion. Newbies might believe your moniker is for Anavex to succeed, which we know is not true. 😉
Investor, you, too, should make a change with your tag line as your remarks don't really reflect the "... the sooner we will get rich!" Maybe, it should read:
This is pointing towards you, Investor!!
https://www.bizpacreview.com/2024/01/16/dr-drew-warns-of-extremely-worrisome-data-and-trends-revealed-in-marijuana-studies-1428111/?utm_campaign=bizpac&utm_content=Newsletter&utm_medium=Newsletter&utm_source=Get%20Response&utm_term=EMAIL
Possibly, it won't take long to find enough people for the 3-71 trial announced today.
Wishful thinking!
I like Lundbeck, as it is involved Anavex now via the Consortium as is Merck and Takeda ... enough power these to cover the non-China world.
george, this would be a great week to release the peer review paper on AD P2b/3 trial. The folks in Davos might take note, given Gates' interview about healthcare costs becoming unaffordable. Might catch the attention of some of the Davos crowd, who though snobs and elitist, hold the $$ strings.
Tomorrow would be nice, TGD!! 😉
I believe psychologists would claim that those who 👍️ their own posts are people of very low esteem.
kund, I think you wear that shoe! Also, don't break your arms, patting yourself on the back.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
The arguments that you, Doc328, Joseph, Steady and froll make are only a pile of 💩 that stink 🦨 to high heaven.
You (and the above) always use %'s that indicate 2-73 isn't up to snuff and demonize and degrade those %'s that indicate its efficiency and its chance of approval.
boi's comment that 85% of drugs reaching the level that has been attained by 2-73 in the EMA approval process are eventually approved is a % for the population reaching that level. Nothing more!
Then, given the new "Hos" breakdown of 2-73's performance, which you and the above claim to be doing in support of your group's diminished %, is further evidence that "you" are not looking at the numbers objectively, but with pre-determined negative views to castigate 2-73 into an inferior drug.
We will all see which group is correct when the EMA decides (or some other agency). The losers should apologize when that decision(s) happens.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
vg, I think george's idea that someone placed the number of shares in the wrong column is correct, given the other notation son the form.
P.S. Agree that kevin was not being the helpful poster s/he usually is.
Here, pogue, from Anavex web site under "Investor Material."
https://jpmorgan.metameetings.net/events/healthcare24/sessions/49893-anavex-life-sciences/webcast/general_signin?gpu_only=true&kiosk=true
vg, if not answered before, I see "A" in transaction code for both and "D" in ownership column for both (per george's post with the links).
Seems consistent for each with the other.
Sorry, if I did not understand your concern.
P.S. $10.09 was ending price on June 27, 2022.
gerry, which journals are in the Tier 1 range from your experience? Why highlight Lancet at this time?
Hosai, or whatever name you went by in an earlier life here, IMO, the markets Anavex is going after are larger that Karuna's when looking at the big picture though Karuna is in the neuro field as well. Should Anavex reach the same stages as Karuna, it will commend a larger price if it were to sell ... which is not my choice for a long time.
Congrats to KRTX; now, let's get it done for your stakeholders, TGD and Anavex people!!
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
plex, give 12x a 👍️ if you like the post ... which you seem to like!
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
As a fellow 🦨, he never had a foot ... other than 💩!!
Given you are a BOT ... who cares!!! 💩🦨
I don't believe the LP has completed the OLE, thus no data. Positive is that 93% are in the Compassionate Use group after the OLE.
He was, probably, addressing the BMY purchase of Karuna Therapeutics, Inc. (KRTX), announced last month. One similarity is it had no commercial operations either, receiving some "license and other revenue", per last year's 10-K.
Still, don't see slide deck on Anavex web site.